xenon has been researched along with Hypoxia-Ischemia, Brain in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (28.57) | 29.6817 |
| 2010's | 19 (54.29) | 24.3611 |
| 2020's | 6 (17.14) | 2.80 |
| Authors | Studies |
|---|---|
| An, Z; Jiang, H; Li, T; Liu, Y; Qin, M; Sun, M; Wei, H | 1 |
| Dickinson, R; Edge, CJ; Franks, NP; Harris, K; Koziakova, M; White, IL | 1 |
| Chakkarapani, E; Dingley, J; Lee-Kelland, R; Okano, S; Scull-Brown, E; Thoresen, M | 1 |
| Chidekel, A; Mosko, JJ; Shaffer, TH; Wolfson, MR; Zhu, Y | 1 |
| Htun, Y; Kusaka, T; Nakamura, S | 1 |
| Cohen, N; Grant, S; Menassa, DA; Phillips, T; Thoresen, M | 1 |
| Cheng, Y; Cui, Y; Sun, H; Wu, X; Xin, W; Yu, J; Yu, Y; Zhang, J; Zhang, M; Zhu, W | 1 |
| Jiang, H; Jiang, J; Li, L; Peng, X; Shi, X; Xi, H; Yin, X; Zhang, L; Zhao, J | 1 |
| Amer, AR; Oorschot, DE | 1 |
| Cheong, JL; Davis, PG; Rüegger, CM | 1 |
| McNally, MA; Soul, JS | 1 |
| Cheung, PY; Schmölzer, GM; Solevåg, AL | 1 |
| Aquilina, K; Chakkarapani, E; Dingley, J; Liu, X; Osredkar, D; Thoresen, M | 1 |
| Ferriero, DM; Juul, SE | 1 |
| Chakkarapani, E; Dingley, J; Elstad, M; Liu, X; Sabir, H; Scull-Brown, E; Thoresen, M; Tooley, J | 1 |
| Dingley, J; Liu, X; Sabir, H; Smit, E; Thoresen, M; Walløe, L | 1 |
| Dingley, J; Liu, X; Scull-Brown, E; Thoresen, M | 1 |
| Maes, E; Osredkar, D; Sabir, H; Thoresen, M; Wood, T | 1 |
| Juul, SE; McAdams, RM | 1 |
| Chakkarapani, E; Dingley, J; Hobbs, CE; Thoresen, M; Wood, T | 1 |
| Coburn, M; Fries, M; Kottmann, K; Kuru, TH; Nolte, KW; Rossaint, R; Timper, A; Weis, J | 1 |
| Aal-Shaya, WA; Al-Faridi, K; Halawani, MM; Taha, WS; Tawfeeq, NA | 1 |
| Banks, P; Dickinson, R; Franks, NP | 1 |
| Cilio, MR; Ferriero, DM | 1 |
| Chakkarapani, E; Dingley, J; Liu, X; Thoresen, M; Walloe, L | 1 |
| Johnson, MR; Ma, D; Maze, M; Petrides, E; Rei Fidalgo, AM; Robertson, NJ; Sanders, RD; Terrando, N; Wu, X; Yang, T; Zhuang, L | 1 |
| Downie, NA; Faulkner, SD; Kerr, SA; Mercer, CJ; Robertson, NJ; Sanders, RD | 1 |
| Lobo, N; Ma, D; Rizvi, M; Yang, B | 1 |
| Fujii, M; Kato, S; Maekawa, T; Nishizaki, T; Nogami, K; Oda, Y; Sadamitsu, D; Suzuki, M; Yamashita, S | 1 |
| Akimov, S; Franks, NP; Hossain, M; Lim, T; Luo, Y; Ma, D; Maze, M; Pettet, GK; Sanders, RD | 1 |
| Arshad, M; Battson, RM; Chow, A; Edwards, AD; Franks, NP; Hossain, M; Ma, D; Maze, M; Mehmet, H; Sanders, RD | 1 |
| Dingley, J; Porter, H; Thoresen, M; Tooley, J | 1 |
| Franks, NP; Hossain, M; Ma, D; Martin, JL; Maze, M; Sanders, RD; Xu, J | 1 |
| Dingley, J; Ferguson, J; Hobbs, C; Stone, J; Thoresen, M | 1 |
| Aquilina, K; Chakkarapani, E; Dingley, J; Hobbs, C; Thoresen, M; Tucker, A | 1 |
10 review(s) available for xenon and Hypoxia-Ischemia, Brain
| Article | Year |
|---|---|
Hydrogen and therapeutic gases for neonatal hypoxic-ischemic encephalopathy: potential neuroprotective adjuncts in translational research.
Topics: Animals; Animals, Newborn; Antioxidants; Argon; Free Radicals; Gases; Humans; Hydrogen; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Neurons; Neuroprotective Agents; Signal Transduction; Translational Research, Biomedical; Treatment Outcome; Xenon | 2021 |
Xenon Combined With Hypothermia in Perinatal Hypoxic-Ischemic Encephalopathy: A Noble Gas, a Noble Mission.
Topics: Animals; Combined Modality Therapy; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Infant, Newborn, Diseases; Neuroprotective Agents; Xenon | 2018 |
Xenon as an adjuvant to therapeutic hypothermia in near-term and term newborns with hypoxic-ischaemic encephalopathy.
Topics: Child Development; Combined Modality Therapy; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Xenon | 2018 |
Pharmacologic Prevention and Treatment of Neonatal Brain Injury.
Topics: Adrenal Cortex Hormones; Allopurinol; Anesthetics, Inhalation; Anticonvulsants; Antioxidants; Cerebral Intraventricular Hemorrhage; Cyclooxygenase Inhibitors; Darbepoetin alfa; Erythropoietin; Free Radical Scavengers; Hematinics; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Indomethacin; Infant, Newborn; Leukomalacia, Periventricular; Magnesium; Melatonin; Neuroprotection; Prenatal Care; Topiramate; Xenon | 2019 |
Novel interventions to reduce oxidative-stress related brain injury in neonatal asphyxia.
Topics: Acetylcysteine; Allopurinol; Argon; Asphyxia Neonatorum; Cannabinoids; Erythropoietin; Female; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Magnesium Sulfate; Melatonin; Neuroprotective Agents; Oxidative Stress; Pregnancy; Treatment Outcome; Xenon | 2019 |
Pharmacologic neuroprotective strategies in neonatal brain injury.
Topics: Acetylcysteine; Allopurinol; Antioxidants; Ascorbic Acid; Biopterins; Erythropoietin; Excitatory Amino Acid Antagonists; Free Radical Scavengers; Fructose; Humans; Hypoxia-Ischemia, Brain; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Melatonin; Memantine; Neuroprotective Agents; Nitric Oxide Synthase Type III; Resveratrol; Stilbenes; Topiramate; Vitamin E; Xenon | 2014 |
Neonatal Encephalopathy: Update on Therapeutic Hypothermia and Other Novel Therapeutics.
Topics: Anesthetics, Inhalation; Biotin; Central Nervous System Depressants; Cerebral Palsy; Constriction; Erythropoietin; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Intellectual Disability; Melatonin; Stem Cell Transplantation; Survival Rate; Umbilical Cord; Xenon | 2016 |
Traumatic brain injury: neuroprotective anaesthetic techniques, an update.
Topics: Adolescent; Adult; Brain Injuries; Cell Death; Central Nervous System Depressants; Craniocerebral Trauma; Cyclosporine; Dexmedetomidine; Erythropoietin; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Intracranial Hypotension; Isoflurane; Middle Aged; Neuroprotective Agents; Nitrous Oxide; Perioperative Care; Propofol; Resuscitation; Saline Solution, Hypertonic; Xenon; Young Adult | 2009 |
Synergistic neuroprotective therapies with hypothermia.
Topics: Acetylcysteine; Anticonvulsants; Body Temperature; Cannabinoids; Combined Modality Therapy; Erythropoietin; Fructose; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Levetiracetam; Melatonin; Neuroprotective Agents; Piracetam; Topiramate; Xenon | 2010 |
Hypothermia and xenon: novel noble guardians in hypoxic-ischemic encephalopathy?
Topics: Asphyxia Neonatorum; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Neuroprotective Agents; Xenon | 2013 |
1 trial(s) available for xenon and Hypoxia-Ischemia, Brain
| Article | Year |
|---|---|
Xenon ventilation during therapeutic hypothermia in neonatal encephalopathy: a feasibility study.
Topics: Anesthesia, Closed-Circuit; Asphyxia Neonatorum; Brain Damage, Chronic; Dose-Response Relationship, Drug; Feasibility Studies; Follow-Up Studies; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant; Infant, Newborn; Neurologic Examination; Tertiary Care Centers; Xenon | 2014 |
24 other study(ies) available for xenon and Hypoxia-Ischemia, Brain
| Article | Year |
|---|---|
Xenon attenuates hypoxic-ischemic brain damage by inhibiting autophagy in neonatal rats.
Topics: Animals; Animals, Newborn; Autophagy; Beclin-1; Brain; Hypothermia; Hypoxia; Hypoxia-Ischemia, Brain; Microtubule-Associated Proteins; Rats; Rats, Sprague-Dawley; Xenon | 2023 |
Noble gas neuroprotection: xenon and argon protect against hypoxic-ischaemic injury in rat hippocampus in vitro via distinct mechanisms.
Topics: Animals; Argon; Disease Models, Animal; Female; Hippocampus; Hypoxia-Ischemia, Brain; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Neuroprotection; Neuroprotective Agents; Rats; Xenon | 2019 |
Closed circuit xenon delivery for 72h in neonatal piglets following hypoxic insult using an ambient pressure automated control system: Development, technical evaluation and pulmonary effects.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Humans; Hypothermia, Induced; Hypoxia; Hypoxia-Ischemia, Brain; Neuroprotective Agents; Oxygen; Respiration, Artificial; Swine; Xenon | 2020 |
Effects of xenon gas on human airway epithelial cells during hyperoxia and hypothermia.
Topics: Anesthetics, Inhalation; Cells, Cultured; Humans; Hyperoxia; Hypothermia; Hypoxia-Ischemia, Brain; Inflammation; Inflammation Mediators; Interleukin-6; Interleukin-8; Respiratory Mucosa; Tight Junctions; Treatment Outcome; Xenon | 2020 |
The effects of Xenon gas inhalation on neuropathology in a placental-induced brain injury model in neonates: A pilot study.
Topics: Asphyxia Neonatorum; Brain Injuries; Female; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant, Newborn; Pilot Projects; Pregnancy; Xenon | 2021 |
Attenuation of the mutual elevation of iron accumulation and oxidative stress may contribute to the neuroprotective and anti-seizure effects of xenon in neonatal hypoxia-induced seizures.
Topics: Animals; Animals, Newborn; Hypoxia; Hypoxia-Ischemia, Brain; Iron; Mice; Mice, Inbred C57BL; Neuroprotection; Neuroprotective Agents; Oxidative Stress; Seizures; Xenon | 2020 |
Impact of Xenon on CLIC4 and Bcl-2 Expression in Lipopolysaccharide and Hypoxia-Ischemia-Induced Periventricular White Matter Damage.
Topics: Animals; Animals, Newborn; Apoptosis; Chloride Channels; Hypoxia-Ischemia, Brain; Lipopolysaccharides; Neurons; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; White Matter; Xenon | 2018 |
Effects of xenon and hypothermia on cerebrovascular pressure reactivity in newborn global hypoxic-ischemic pig model.
Topics: Adaptation, Physiological; Animals; Animals, Newborn; Arterial Pressure; Cerebrovascular Circulation; Data Interpretation, Statistical; Hypothermia; Hypoxia-Ischemia, Brain; Intracranial Pressure; Neuroprotective Agents; Regression Analysis; Sus scrofa; Xenon | 2013 |
Combined treatment of xenon and hypothermia in newborn rats--additive or synergistic effect?
Topics: Animals; Animals, Newborn; Combined Modality Therapy; Dose-Response Relationship, Drug; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Neuroprotective Agents; Rats; Rats, Wistar; Temperature; Time Factors; Xenon | 2014 |
Adding 5 h delayed xenon to delayed hypothermia treatment improves long-term function in neonatal rats surviving to adulthood.
Topics: Animals; Animals, Newborn; Hippocampus; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Motor Skills; Rats; Rats, Wistar; Statistics, Nonparametric; Time Factors; Xenon | 2015 |
Xenon Combined with Therapeutic Hypothermia Is Not Neuroprotective after Severe Hypoxia-Ischemia in Neonatal Rats.
Topics: Animals; Animals, Newborn; Brain; Cell Count; Combined Modality Therapy; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Lateral Ventricles; Neurons; Neuroprotective Agents; Rats, Wistar; Xenon | 2016 |
Cooling combined with immediate or delayed xenon inhalation provides equivalent long-term neuroprotection after neonatal hypoxia-ischemia.
Topics: Administration, Inhalation; Animals; Animals, Newborn; Cold Temperature; Disease Models, Animal; Female; Hypoxia-Ischemia, Brain; Male; Neuroprotective Agents; Rats; Sex Factors; Time Factors; Xenon | 2009 |
Early administration of xenon or isoflurane may not improve functional outcome and cerebral alterations in a porcine model of cardiac arrest.
Topics: Anesthetics, Inhalation; Animals; Brain; Cardiopulmonary Resuscitation; Disease Models, Animal; Drug Administration Schedule; Heart Arrest; Hippocampus; Hypoxia-Ischemia, Brain; Isoflurane; Male; Psychomotor Performance; Sus scrofa; Xenon | 2009 |
Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia.
Topics: Anesthetics, Inhalation; Animals; Binding, Competitive; Coloring Agents; Excitatory Amino Acid Antagonists; Glucose; Glycine; Glycine Agents; Hippocampus; Hyperbaric Oxygenation; Hypoxia-Ischemia, Brain; Indoles; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Organ Culture Techniques; Propidium; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Xenon | 2010 |
Xenon offers stable haemodynamics independent of induced hypothermia after hypoxia-ischaemia in newborn pigs.
Topics: Animals; Animals, Newborn; Blood Pressure; Hemodynamics; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Swine; Xenon | 2012 |
Xenon and sevoflurane provide analgesia during labor and fetal brain protection in a perinatal rat model of hypoxia-ischemia.
Topics: Analgesia; Animals; Animals, Newborn; Apoptosis; Brain; Caspase 3; Cell Survival; Cohort Studies; Female; Fetal Hypoxia; Hippocampus; Hypoxia-Ischemia, Brain; Labor Pain; Memory Disorders; Methyl Ethers; Neuroprotective Agents; Posterior Horn Cells; Pregnancy; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Sevoflurane; Xenon | 2012 |
A xenon recirculating ventilator for the newborn piglet: developing clinical applications of xenon for neonates.
Topics: Air; Anesthesiology; Animals; Animals, Newborn; Automation; Calibration; Hypoxia-Ischemia, Brain; Isoflurane; Male; Oxygen; Prospective Studies; Reproducibility of Results; Respiration, Artificial; Swine; Time Factors; Treatment Outcome; Xenon | 2012 |
Analysis of magnetic resonance imaging (MRI) morphometry and cerebral blood flow in patients with hypoxic-ischemic encephalopathy.
Topics: Adolescent; Adult; Aged; Blood Circulation Time; Cerebrovascular Circulation; Child; Female; Humans; Hypoxia-Ischemia, Brain; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, X-Ray Computed; Xenon | 2004 |
Xenon preconditioning reduces brain damage from neonatal asphyxia in rats.
Topics: Animals; Animals, Newborn; Asphyxia; Brain-Derived Neurotrophic Factor; Cells, Cultured; Coculture Techniques; Cyclic AMP Response Element-Binding Protein; Dose-Response Relationship, Drug; Hippocampus; Hypoxia-Ischemia, Brain; Ischemic Preconditioning; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neuroglia; Neurons; Nitrogen; Nitrous Oxide; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Time Factors; Up-Regulation; Xenon | 2006 |
Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia.
Topics: Analysis of Variance; Animals; Animals, Newborn; Apoptosis; Asphyxia; bcl-2-Associated X Protein; bcl-X Protein; Blotting, Western; Body Temperature; Brain; Caspase 3; Caspases; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Excitatory Amino Acid Antagonists; Flow Cytometry; Gene Expression Regulation; Glucose; Hypothermia; Hypoxia; Hypoxia-Ischemia, Brain; Immunohistochemistry; Indoles; L-Lactate Dehydrogenase; Male; Mice; Mice, Inbred BALB C; Motor Activity; Necrosis; Neurons; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Recovery of Function; Temperature; Time Factors; Xenon | 2005 |
Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia.
Topics: Anesthetics, Inhalation; Animals; Animals, Newborn; Asphyxia; Brain; Female; Hypoxia-Ischemia, Brain; Male; N-Methylaspartate; Neuroprotective Agents; Pilot Projects; Random Allocation; Rats; Receptors, N-Methyl-D-Aspartate; Temperature; Time Factors; Xenon | 2006 |
Asynchronous administration of xenon and hypothermia significantly reduces brain infarction in the neonatal rat.
Topics: Animals; Animals, Newborn; Brain Infarction; Combined Modality Therapy; Disease Models, Animal; Drug Administration Schedule; Female; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Male; Neuroprotective Agents; Rats; Xenon | 2007 |
Xenon/hypothermia neuroprotection regimes in spontaneously breathing neonatal rats after hypoxic-ischemic insult: the respiratory and sedative effects.
Topics: Anesthetics, Inhalation; Animals; Animals, Newborn; Blood Glucose; Body Temperature; Carbon Dioxide; Carotid Arteries; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hydrogen-Ion Concentration; Hypercapnia; Hypothermia, Induced; Hypoxia; Hypoxia-Ischemia, Brain; Lactic Acid; Ligation; Male; Motor Activity; Neuroprotective Agents; Oxygen; Rats; Rats, Wistar; Respiratory Mechanics; Time Factors; Xenon | 2008 |
Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia.
Topics: Anesthetics, Inhalation; Animals; Animals, Newborn; Behavior, Animal; Body Temperature; Combined Modality Therapy; Disease Models, Animal; Female; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Male; Neuroprotective Agents; Rats; Recovery of Function; Xenon | 2008 |